Kodiak Sciences (KOD) Payables (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Payables came in at $11.3 million in Q1 2026, up 73.38% YoY from $6.5 million in Q1 2025, and down 11.81% on a QoQ basis from $12.9 million in Q4 2025.
Kodiak Sciences (KOD) Payables (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 10 years of Payables data on file, last reported at $11.3 million in Q1 2026.
- Quarterly Payables rose 73.38% year-over-year to $11.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (up 73.38% YoY) and the FY2025 annual result came in at $12.9 million, up 228.56% from the prior year.
- Payables slipped to $11.3 million in Q1 2026, from $12.9 million in the prior quarter.
- In the past five years, Payables ranged from a high of $38.6 million in Q3 2023 to a low of $1.9 million in Q2 2024.
- A 5-year average of $11.0 million and a median of $10.4 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables soared 653.51% — and 2024, when it tumbled 91.47%.
- Tracing KOD's Payables over 5 years: stood at $9.1 million in 2022, then jumped by 49.05% to $13.6 million in 2023, then plunged by 71.23% to $3.9 million in 2024, then jumped by 228.56% to $12.9 million in 2025, then retreated by 11.81% to $11.3 million in 2026.
- The last three Payables figures came in at $11.3 million (Q1 2026), $12.9 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.64 Mn |
| Mar 31, 2026 | 11.34 Mn |
| Dec 31, 2025 | 12.86 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | 6.54 Mn |
| Dec 31, 2024 | 3.92 Mn |
| Sep 30, 2024 | 3.29 Mn |
| Jun 30, 2024 | 1.87 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 13.61 Mn |
| Sep 30, 2023 | 38.59 Mn |
| Jun 30, 2023 | 12.35 Mn |
| Mar 31, 2023 | 6.26 Mn |
| Dec 31, 2022 | 9.13 Mn |
| Sep 30, 2022 | 15.61 Mn |
| Jun 30, 2022 | 20.63 Mn |
| Mar 31, 2022 | 13.07 Mn |
| Dec 31, 2021 | 12.43 Mn |
| Sep 30, 2021 | 13.76 Mn |